TCM
RXDX

TimesSquare Capital Management’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

TimesSquare Capital Management’s Portfolio RXDX Stock Details RXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-164,055
Closed -$17.6M – 190
2023
Q1 		$17.6M Buy
+164,055
New +$17.6M 0.26% 131